Dr. Reddy’s Stakes Claim In U.S. OTC Market With Leiner Deal
This article was originally published in The Tan Sheet
Executive Summary
Dr. Reddy's Laboratories' foothold in the U.S. OTC drug market appears ready for expansion after the firm signed an exclusive 15-year OTC product development and marketing agreement with Leiner Health Products
You may also be interested in...
Leiner Ownership Expected To Change Hands In Recapitalization Deal
North Castle Partners is reportedly in the second round of talks to sell its stake in Leiner Health Products to another private equity firm
Leiner Ownership Expected To Change Hands In Recapitalization Deal
North Castle Partners is reportedly in the second round of talks to sell its stake in Leiner Health Products to another private equity firm
Leiner Ownership Expected To Change Hands In Recapitalization Deal
North Castle Partners is reportedly in the second round of talks to sell its stake in Leiner Health Products to another private equity firm